Main navigation
You are here
- Home
- Media
- Photo library
- Board and management
Board and management photo library
David Brennan
David Brennan
Chief Executive Officer
David Brennan was appointed Chief Executive Officer of AstraZeneca effective 1 Jan 2006. Read Biography
Not signed in
Page tools
Share price
- London
-
28.96 GBP - New York
-
44.64 USD - Stockholm
-
313.80 SEK
At 17-Mar-2010 19:12 GMT
Detailed share price